SEC Filings
Frazier Life Sciences Public Fund Reports 5.9% Stake In Q32 Bio, 1,755,116 Shares
A Schedule 13G lists the fund's position, plus two sister Frazier funds holding 0.1% and 0.4%, with an October 2 trigger date.
SEC Filings
A Schedule 13G lists the fund's position, plus two sister Frazier funds holding 0.1% and 0.4%, with an October 2 trigger date.
SEC Filings
The New York manager filed a passive ownership disclosure and certified it holds the shares without aiming to influence control.
SEC Filings
An 8-K says Zarcone told directors on October 6 she will leave, and that the move is not the result of any disagreement.
SEC Filings
The payout comes with two years of equity vesting treatment and takes effect October 14 unless Donnelly revokes the agreement.
SEC Filings
An 8-K shows higher leverage limits and a $100 million EBITDA addback for the September and December quarters, with restrictions on liens and payouts.
SEC Filings
An 8-K shows Peter Williams also gets faster vesting on 12,184 RSUs and 11,347 PSUs and twelve months of COBRA reimbursement.
SEC Filings
Sachem Head and three co-filers now show no Sotera Health common stock, with October 9, 2026 as the triggering event date.
SEC Filings
An 8-K shows Lucid now owes about $2.1 billion on the facility, with about $400 million of borrowing capacity left.
SEC Filings
The 8-K says the board seated Roche effective immediately; her committee assignments, if any, are not yet set.
SEC Filings
An 8-K filed Friday sets the exit date for St. Romain, who told Pool in a January filing he planned to retire during 2026.
SEC Filings
The gas utility's ten-year notes were offered at 99.638% of face value and leave it about $691.4 million after costs.
SEC Filings
The pay was left open when Greer's appointment was first reported, and the board can still adjust it.